It takes the average reader 2 hours and 49 minutes to read Algae-Based Biopharmaceuticals by Sergio Rosales-Mendoza
Assuming a reading speed of 250 words per minute. Learn more
This book constitutes a key reference on the use of algae in the biopharmaceuticals production field; providing an updated outlook on the achievements accomplished thus far and transmitting a prospective view for this biotechnological application. This book provides a detailed description of the technology as well as an updated outlook of the strides achieved thus far in the field of algae-based biopharmaceuticals. Algae constitute attractive expression hosts for the production of recombinant proteins with medical applications. Among the features that make them attractive candidates are: low cost, fast growth, wide biosynthetic capacity, and absence of human pathogens; which constitute substantial advantages with respect to bacterial and mammalian systems. First, the features of algae as convenient hosts for the production of BFs are analyzed in terms of production costs, biosynthetic capacity, and safety (Chapter 1). Second, the genetic engineering tools for algae-species are described. Nuclear and chloroplast-based expression approaches are analyzed and compared in terms of biosynthetic advantages, gene expression complexity, and DNA transfer approaches (Chapter 2). In the following sections, chapters 3 to 7, the state of the art on producing distinct types of BFs in algae species is presented. Although this book is mainly focused on BFs, considering that the production of compounds with health-promoting properties are achieved using genetically-engineered algae strains, chapter 8 deals with nutraceuticals. In the ninth chapter, the developments reported thus far are placed in perspective and challenges for the field are discussed. Critical future prospects comprise the following: optimizing large-scale production in bioreactors, implementing glycoengineering approaches, optimizing nuclear expression, exploring new approaches for oral delivery, and implementing regulatory frameworks to accomplish technology transfer and regulatory approval of algae-made BFs.
Algae-Based Biopharmaceuticals by Sergio Rosales-Mendoza is 166 pages long, and a total of 42,496 words.
This makes it 56% the length of the average book. It also has 52% more words than the average book.
The average oral reading speed is 183 words per minute. This means it takes 3 hours and 52 minutes to read Algae-Based Biopharmaceuticals aloud.
Algae-Based Biopharmaceuticals is suitable for students ages 10 and up.
Note that there may be other factors that effect this rating besides length that are not factored in on this page. This may include things like complex language or sensitive topics not suitable for students of certain ages.
When deciding what to show young students always use your best judgement and consult a professional.
Algae-Based Biopharmaceuticals by Sergio Rosales-Mendoza is sold by several retailers and bookshops. However, Read Time works with Amazon to provide an easier way to purchase books.
To buy Algae-Based Biopharmaceuticals by Sergio Rosales-Mendoza on Amazon click the button below.
Buy Algae-Based Biopharmaceuticals on Amazon